NWBO Stock Overview – The Average Joe

Newsletter

Latest Issues Subscribe

Company

About Us Jobs
×

Become a better investor with our free daily newsletters

Join 250,000+ investors discovering new market trends and ideas.

PNK:NWBO

Loading...

Market cap

$Loading...

Sector

Loading...

Dividend Yield

Loading...

52-week range

Loading... Loading...

Expected earnings date

August 7, 2024

Description

Loading...

Price Performance

1M 6M 1Y 5Y 10Y
$NWBO N/A N/A N/A N/A N/A
S&P500 N/A N/A N/A N/A N/A

Valuation

P/E Ratio (TTM) P/S Ratio (TTM)
Northwest Biotherapeutics, Inc. Loading... Loading...
Sector Name Loading... N/A

Related

IMUCImmunoCellular Therapeutics, Ltd.-10.5%
CLDXCelldex Therapeutics, Inc.1.7%
CVMCEL-SCI Corporation-3.1%
ONCSOncoSec Medical Incorporated31.9%
ADXSAdvaxis, Inc.16.3%

Analyst Ratings

Buy Loading...
Hold Loading...
Sell Loading...

Financial Overview

FY 2014FY 2015FY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023
Revenue1M2M1M0M0M2M1M1M2M2M
Growth Rate-19.6%-64.2%-46.1%22.6%485.0%-46.4%-22.2%67.5%14.8%
EBITDA-120M-126M-85M-57M-43M-27M-86M-53M-66M-54M
EBITDA Margin-8,255.6%-7,258.7%-13,604.7%-16,826.2%-10,550.0%-1,139.5%-6,675.4%-5,250.0%-3,900.7%-2,783.4%
Net Income-136M-115M-80M-73M-36M-24M-538M179M-137M-63M
NI Margin-9,328.3%-6,598.1%-12,875.4%-21,768.8%-8,687.9%-978.1%-41,701.4%17,823.5%-8,131.2%-3,240.1%